Mona Alattar in Houston, Texas

Home Texas Houston

Mona Alattar has Hematology/oncology as her primary medical specialty. Their primary office is: 925 Gessner Rd in Houston, Texas.

They're a part of the: Oncology Consultants, P. A.. medical group which has around 38 members. You can call their office at 713-827-9525 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2008 (around 16 years of experience). They are listed as doing telehealth appointments.

Mona Lisa Alattar Office Phone and Directions

Mona Alattar
Oncology Consultants, P. A..
925 Gessner Rd
Houston, Texas 77024
713-827-9525

Patient Ratings
Please rate your experience with Mona Alattar below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 713-827-9525

Enter a starting address:

Healthcare Info for Mona Alattar

Medical School: Sorry, her university is not listed
Graduation Year: 2008
The Primary Medical Specialty for Mona Alattar is listed as: Hematology/oncology
Approximate Years of Experience: 16
PAC (PECOS ID)#: 3678722899
NPI #: 1558624239
NPI Created On: 06/19/2012
NPI Last Updated Listed as: 06/07/2016
Primary Taxonomy Code: 207RH0003X
License Number:
P5768
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Community Health Choice
Molina Marketplace
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Arabic.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Blood creatinine level
Complete blood cell count (red cells, white blood cell, platelets), automated test
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Physician telephone patient service, 11-20 minutes of medical discussion
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
Annual depression screening, 15 minutes
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788385717

Being Disputed:: No

Product Related: No

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788385719

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788385721

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788385723

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788385725

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788385727

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788385729

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788385731

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788385733

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788385735

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Hematology/oncology Professionals in Houston

1.
Mahesh Swaminathan

1515 Holcombe Blvd
Houston, TX
Physicians Referral Service

2.
Quillan Huang

1504 Taub Loop
Houston, TX
Baylor College Of Medicine

3.
Hima Boppidi

2727 W Holcombe Blvd
Houston, TX
Kelsey-seybold Medical Group, Pllc

4.
Naval Daver

1515 Holcombe Blvd
Houston, TX
Physicians Referral Service

5.
Naval Daver

2130 W Holcombe Blvd
Houston, TX
Physicians Referral Service

6.
William Wierda

1515 Holcombe Blvd
Houston, TX
Physicians Referral Service

Providers in Oncology Consultants, P. A..

1.Mona Alattar

925 Gessner Rd
Houston Tx 77024-2645
Oncology Consultants, P. A..
Hematology/oncology

2.Munaf Alkadimi

2130 W Holcombe Blvd
Houston Tx 77030-3306
Oncology Consultants, P. A..
Medical Oncology

3.Munaf Alkadimi

1920 Country Place Pkwy
Pearland Tx 77584-1962
Oncology Consultants, P. A..
Medical Oncology

4.Ricardo Alvarez

925 Gessner Rd
Houston Tx 77024-2645
Oncology Consultants, P. A..
Internal Medicine

5.Ricardo Alvarez

23960 Katy Fwy
Katy Tx 77494-0886
Oncology Consultants, P. A..
Internal Medicine

6.Meaghan Brown

925 Gessner Rd
Houston Tx 77024-2645
Oncology Consultants, P. A..
Nurse Practitioner

View all 38 members of Oncology Consultants, P. A.. medical group